skip
net ir
Japanese
Nomura Investment Forum 2016
What's New

4523 Eisai Co., Ltd.
CEO Haruo Naito
Information Meeting
2158 FRONTEO, Inc.
CEO and Chairman Masahiro Morimoto
Quarterly Earnings Summary The 3rd Quarter of Fiscal Year ending March 31, 2017
4578 Otsuka Holdings Co., Ltd.
Tatsuo Higuchi President and Representative Director, CEO
FY2016 Consolidated Financial Results
3659 NEXON Co., Ltd.
President and Chief Executive Officer Owen Mahoney
Investor Presentation Q4 2016
4507 SHIONOGI & CO., LTD.
Director, Senior Executive Officer, Senior Vice President, Corporate Strategy Division Takuko Sawada
3rd Quarter of Fiscal 2016 Financial Results Conference Call
4523 Eisai Co., Ltd.
Senior Vice President Ryohei Yanagi
Q3 FY2016 (Fiscal Year Ending March 31, 2017) Financial Results Presentation
4204 SEKISUI CHEMICAL CO., LTD.
Director, Executive Officer Head of Business Strategy Dept. Yoshiyuki Hirai
Presentation of Financial Results for the 3rd Quarter of FY2016
4502 Takeda Pharmaceutical Company Limited
President and Chief Executive Officer
Christophe Weber
Conference Call for the Announcement of 3rd Quarter Financial Results for Fiscal Year 2016
7013 IHI Corporation
Managing Executive Officer, General Manager of Finance & Accounting Division Mikio Mochizuki
Financial Results for Third Quarter FY2016 (for the year ending March 31, 2017)
8604 Nomura Holdings, Inc.
CFOTakumi Kitamura
Third Quarter Operating Results for Fiscal Year Ending March 2017
4503 Astellas Pharma Inc.
Senior Corporate Executive, Chief Financial Officer Yasumasa Masuda
Q3/FY2016 FINANCIAL RESULTS ENDED DECEMBER 31, 2016
4502 Takeda Pharmaceutical Company Limited
Christophe Weber President & Chief Executive Officer
Conference Call Takeda to Acquire ARIAD Pharmaceuticals
5938 LIXIL Group Corporation
President & CEO, LIXIL Group Kinya Seto
Nomura Investment Forum 2016
4503 Astellas Pharma Inc.
President and CEO Yoshihiko Hatanaka
R&D MEETING 2016
8604 Nomura Holdings, Inc.
Group CEOKoji Nagai
Nomura Investment Forum 2016
8766 Tokio Marine Holdings, Inc.
President Tsuyoshi Nagano
FY2016 Business Plan Update
8630 Sompo Holdings, Inc.
President(Group CEO) Kengo Sakurada
Progress of Mid-term Management Plan
4578 Otsuka Holdings Co., Ltd.
Senior Managing Director Atsumasa Makise
Consolidated Financial Results FY2016 Q3
2158 FRONTEO, Inc.
CEO and Chairman Masahiro Morimoto
Quarterly Earnings Summary SummaryThe 2nd Quarter of Fiscal Year ending March 31, 2017
4507 SHIONOGI & CO., LTD.
President and CEO Isao Teshirogi, Ph.D.
1st Half of Fiscal 2016 Financial Results
4536 Santen Pharmaceutical Co., Ltd.
President & CEO Akira Kurokawa
Investor Meeting on Q2 FY2016 Results
7013 IHI Corporation
President and COO Tsugio Mitsuoka
Financial Results for Second Quarter FY2016 (for the year ending March 31, 2017)
8766 Tokio Marine Holdings, Inc.
President Tsuyoshi Nagano
IR Conference for New Mid-Term Business Plan
4502 Takeda Pharmaceutical Company Limited
President & Chief Executive Officer Christophe Weber
Conference for the Announcement of 2nd Quarter Financial Results for Fiscal Year 2016
4503 Astellas Pharma Inc.
President and CEO YoshihikoHatanaka
Q2/FY2016 FINANCIAL RESULTS ENDED SEPTEMBER30, 2016
7013 IHI Corporation
President and COO Tsugio Mitsuoka
Presentation of Revisions to First Half and Full-Year Consolidated Results Forecasts and Planned Dividends for the Fiscal Year Ending March 31, 2017
4523 Eisai Co., Ltd.
CEO Haruo Naito, KBE
2016 Eisai Scientific Day (Oncology Field )
4523 Eisai Co., Ltd.
CEO Haruo Naito,KBE
2016 Eisai Scientific Day (Alzheimer's Disease & Dementia Field)
4502 Takeda Pharmaceutical Company Limited
President & CEO Christophe Weber
Takeda IR Day 2016
8766 Tokio Marine Holdings, Inc.
President President Group CEO Tsuyoshi Nagano
Mid-Term Business Plan ''To Be a Good Company 2017'' FY2016 Business Plan

Precautions in use
Nomura IR assumes no responsibility for correctness, validity or any other nature of the contents on this server.
No act such as alteration, modification or addition to the contents is permitted.
Since the contents on this server are not intended to solicit investment, our company has no liability for any trouble related to investment made by any audience based on the contents of this site. Investors are required to decide at their own discretion.
Nomura IR assumes no responsibility for correctness, validity or any other nature of information, including its format and details, obtained from any site linked from our site.

up
Download Plug-in
Get Adobe Reader
Windows Media Player
Real Player
Copyright (c) 2004 Nomura Investor Relations Co., Ltd. All Rights Reserved.
NIR